Amyloidosis is a rare disease that is due to amyloid protein build up in the organs. The cause is unknown and is thought to result from many factors. Treatments are available to help manage symptoms and even control the production of amyloid protein. Since It is a disease that affects multiple organs/systems in the body, it requires much expertise and multidisciplinary approach. Learn more about this rare disease by joining us in a free online chat with Dr. Mazen Hanna, Cardiologist and Co-director of Amyloidosis Center at Cleveland Clinic and Dr. Frederic Reu, Oncologist at Cleveland Clinic.
Mazen Hanna, MD, is a Cardiologist with advanced training in heart failure and cardiac transplantation. He is the local Principal Investigator for two international multicenter trials that are currently enrolling patients with congestive heart failure. He also has experience with left ventricular assist devices.
Frederic Reu, MD, is an oncologist at Cleveland Clinic whose specialty interests include Multiple Myeloma, Light Chain Amyloidosis and Plasma Cell Disorders.
This Health Chat will open on
Sunday, May 9, 2010
to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.